Oct. 20 at 7:25 PM
Hologic shares rose Monday after reports that Blackstone and TPG are in advanced negotiations to acquire the medical device maker in a deal valued at more than
$17 billion, including debt. According to Bloomberg, the talks are progressing but no final agreement has been reached. Both private-equity firms declined to comment, and Hologic has not publicly responded.
The stock climbed 2.7% to
$71.75, outperforming the S&P 500’s 1.1% gain. Hologic’s enterprise value was around
$16 billion as of Friday, including nearly $ 1 billion in debt. The latest report follows earlier speculation in May that the company rejected a
$16 billion take-private offer from the same firms.
Despite its strong position in women’s health diagnostics and imaging, Hologic shares have slipped about 1% year to date, weighed down by macroeconomic uncertainty and lower demand for breast cancer screening products post-pandemic.
$HOLX $TPG $SPX